345 related articles for article (PubMed ID: 7008825)
1. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
Gray RH; Parker RA; Diethelm P
Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
[TBL] [Abstract][Full Text] [Related]
2. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
3. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Swenson I; Khan AR; Jahan FA
Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
[TBL] [Abstract][Full Text] [Related]
4. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
[TBL] [Abstract][Full Text] [Related]
5. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
Fraser IS
Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
[TBL] [Abstract][Full Text] [Related]
6. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
Fraser IS
Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
[TBL] [Abstract][Full Text] [Related]
7. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
[TBL] [Abstract][Full Text] [Related]
8. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
9. Acceptability of injectable contraceptives in Assiut, Egypt.
Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
[TBL] [Abstract][Full Text] [Related]
10. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
Cochrane Database Syst Rev; 2013; 3():CD004568. PubMed ID: 23641480
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
[TBL] [Abstract][Full Text] [Related]
12. Assessing changes in vaginal bleeding patterns in contracepting women.
Machin D; Farley TM; Busca B; Campbell MJ; d'Arcangues C
Contraception; 1988 Aug; 38(2):165-79. PubMed ID: 2971504
[TBL] [Abstract][Full Text] [Related]
13. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Schulz KF; d'Arcangues C; Lopez LM
Cochrane Database Syst Rev; 2005 Jul; (3):CD004568. PubMed ID: 16034938
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
15. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD004568. PubMed ID: 18843662
[TBL] [Abstract][Full Text] [Related]
16. Once-a-month estrogen/progestogen injectables.
D'arcangues C
Entre Nous Cph Den; 1991 Dec; (19):15. PubMed ID: 12222332
[TBL] [Abstract][Full Text] [Related]
17. Facts about injectable contraceptives: memorandum from a WHO meeting.
Bull World Health Organ; 1982; 60(2):199-210. PubMed ID: 6213318
[TBL] [Abstract][Full Text] [Related]
18. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
Cochrane Database Syst Rev; 2006 Jul; (3):CD005214. PubMed ID: 16856087
[TBL] [Abstract][Full Text] [Related]
19. Return of fertility in women discontinuing injectable contraceptives.
Fotherby K; Howard G
J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276
[TBL] [Abstract][Full Text] [Related]
20. Acceptability study of the two versus three monthly injectable contraceptives.
Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
